Hyperfine Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS

Ticker Exchange SIC # Website Latest Ticker
HYPR Nasdaq 3845 https://hyperfine.io/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Hyperfine Inc

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results - Mar 21st, 2023 8:05 pm
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023 - Mar 6th, 2023 1:55 pm
Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted Imaging - Feb 28th, 2023 1:55 pm
Hyperfine, Inc. Swoop® Portable MR Imaging® System Receives CE Marking After Meeting Comprehensive New EU MDR Regulations - Feb 21st, 2023 1:55 pm
Hyperfine, Inc. Announces FDA Clearance for Improved AI-Powered Software and Expanded Field of View for the Swoop® Portable MR Imaging® System - Feb 13th, 2023 1:55 pm
Latest Data Demonstrate Potential of the Swoop® Portable MR Imaging® System in the Follow-up of Stroke Patients Who Have Received a Thrombectomy - Feb 9th, 2023 9:10 pm
Hyperfine, Inc. Announces Brett Hale as New Chief Administrative Officer & Chief Financial Officer - Feb 8th, 2023 9:05 pm
Hyperfine Swoop® Point-of-Care MRI System™ Takes the Stage at ISMRM with Twelve Abstract Inclusions - Feb 6th, 2023 11:31 pm
Hyperfine to Present at the 5th Annual Evercore ISI HealthCONx Conference - Nov 22nd, 2022 9:05 pm
Hyperfine Reports Third Quarter 2022 Financial Results - Nov 10th, 2022 9:05 pm
Hyperfine to Announce Third Quarter 2022 Financial Results on November 10, 2022 - Oct 27th, 2022 8:10 pm
Hyperfine Names Maria Sainz President and Chief Executive Officer - Oct 6th, 2022 1:00 pm
BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory Council - Sep 7th, 2022 12:30 pm
Hyperfine to Participate in Upcoming Investor Conferences - Aug 24th, 2022 8:10 pm
Jonathan Rothberg Is The Founder & Vice Chairman of Hyperfine, Inc. (NASDAQ:HYPR) And They Just Picked Up 24% More Shares - Aug 15th, 2022 10:11 am
Hyperfine Reports Second Quarter 2022 Financial Results - Aug 10th, 2022 8:05 pm
Hyperfine to Announce Second Quarter 2022 Financial Results on August 10, 2022 - Jul 20th, 2022 8:15 pm
Hyperfine Announces Zero Radiation Dose Rapid MR Imaging Test for Pediatric Hydrocephalus Patients - Jul 14th, 2022 1:00 pm
Hyperfine Announces CEO Transition - Jun 29th, 2022 8:05 pm
A Hyperfine, Inc. (NASDAQ:HYPR) insider increased their holdings by 4.3% last year - Jun 18th, 2022 12:10 pm